Key Principles in Safely Prescribing Bispecific Antibodies in Heavily Pretreated Patients With Multiple Myeloma iconKey Principles in Safely Prescribing Bispecific Antibodies in Heavily Pretreated Patients With Multiple Myeloma

Key Principles in Safely Prescribing Bispecific Antibodies in Heavily Pretreated Patients With Multiple Myeloma

Jun 8, 2023 3:00pm ‐ Jun 8, 2023 3:30pm

Identification: webccs230608

Speaker(s):

To Extend or Not Extend? Evaluating the Need for Extended Endocrine Therapy in Patients With Early-Stage HR+ Breast Cancer iconTo Extend or Not Extend? Evaluating the Need for Extended Endocrine Therapy in Patients With Early-Stage HR+ Breast Cancer

To Extend or Not Extend? Evaluating the Need for Extended Endocrine Therapy in Patients With Early-Stage HR+ Breast Cancer

Jun 27, 2023 3:00pm ‐ Jun 27, 2023 4:30pm

Identification: webccs230627

Speaker(s):

Management of Patients With Multiple Myeloma Receiving CAR T-Cell Therapy: Timing, Adverse Events, and Coordination of Care iconManagement of Patients With Multiple Myeloma Receiving CAR T-Cell Therapy: Timing, Adverse Events, and Coordination of Care

Management of Patients With Multiple Myeloma Receiving CAR T-Cell Therapy: Timing, Adverse Events, and Coordination of Care

Jul 20, 2023 3:00pm ‐ Jul 20, 2023 3:30pm

Identification: webccs230720

Speaker(s):

Managing Fertility and Treatment-related Side Effects in Premenopausal Patients with Breast Cancer iconManaging Fertility and Treatment-related Side Effects in Premenopausal Patients with Breast Cancer

Managing Fertility and Treatment-related Side Effects in Premenopausal Patients with Breast Cancer

Sep 7, 2023 3:00pm ‐ Sep 7, 2023 4:00pm

Identification: webccs230907

Speaker(s):